Sally C. Pipes
Commentary
The real story behind Trump’s GLP-1 price cut: Markets still rule
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 weight-loss drugs dispensed through Medicare and Medicaid. Both firms have also agreed to sell the drugs at lower prices on Trump’s yet-to-be-developed online marketplace for prescription drugs, TrumpRx. Lilly and ...
Commentary
GAO Provides Yet More Evidence for Why Enhanced Obamacare Subsidies Must Expire
Defrauding the government through Obamacare’s insurance exchanges is shockingly easy, per a new government report. The study found that federal insurance subsidies were granted for 90 percent of the fake exchange accounts set up as part of a Government Accountability Office investigation — at a cost of more than $10,000 ...
Commentary
Despite Dems’ protests, affordable health plans are about to multiply
Obamacare premiums are climbing yet again during open enrollment. But there’s also some good news for cost-conscious shoppers ― a new way to secure affordable coverage without forgoing access to care. This year, many people can buy low-cost “catastrophic” health plans for the very first time. Combine one of these ...
Blog
How did the US become the world’s center of pharmaceutical innovation?
What kinds of policies helped the US surpass Great Britain to become the world’s center of pharmaceutical innovation? I think it was a combination of shrewd reforms on the part of the United States, and self-destructive reforms on the part of Europe and other developed nations. In the 1970s, Europe ...
Commentary
Trade Policy Is The Right Way To Fight Foreign Freeloading
Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports. It’s a perfect example of how the ...
Commentary
‘Soak the Rich’ Won’t Rescue Calif. Healthcare
A group of unions in California has proposed a new plan for paying for healthcare — soak the rich. That’s the idea behind the Billionaire Tax Act, a 2026 ballot initiative that would impose a 5% tax on the state’s billionaires in order to raise money for healthcare programs and ...
Commentary
Competition, not price controls, just slashed GLP-1 prices
Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also dropped ...
Commentary
A Healthy Dose Of Competition Sends Weight-Loss Drug Prices Plummeting
Prices for GLP-1 weight-loss medications are dropping fast. Last week, Novo Nordisk—maker of Ozempic and Wegovy—announced it would cut prices for monthly supplies of both drugs to as low as $349 for existing patients buying directly. For new customers, the price will fall to just $199 a month for the ...
Commentary
Trump got shots because he knows vaccines work
The cold and flu and COVID season is here. Millions of Americans are weighing when and whether to get their shots. It’s an appropriate time to reflect on the power of vaccination and how many lives new shots have saved in recent years. As Senators Bill Cassidy and John Barrasso ...
Commentary
Trump Has a Subsidy Alternative, We Should Take it Seriously
In a social media post earlier this month, President Trump laid out his own alternative to the enhanced Obamacare subsidies that fueled the record-breaking 43-day government shutdown. “I am recommending to Senate Republicans that the Hundreds of Billions of Dollars currently being sent to money sucking Insurance Companies in order ...
The real story behind Trump’s GLP-1 price cut: Markets still rule
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 weight-loss drugs dispensed through Medicare and Medicaid. Both firms have also agreed to sell the drugs at lower prices on Trump’s yet-to-be-developed online marketplace for prescription drugs, TrumpRx. Lilly and ...
GAO Provides Yet More Evidence for Why Enhanced Obamacare Subsidies Must Expire
Defrauding the government through Obamacare’s insurance exchanges is shockingly easy, per a new government report. The study found that federal insurance subsidies were granted for 90 percent of the fake exchange accounts set up as part of a Government Accountability Office investigation — at a cost of more than $10,000 ...
Despite Dems’ protests, affordable health plans are about to multiply
Obamacare premiums are climbing yet again during open enrollment. But there’s also some good news for cost-conscious shoppers ― a new way to secure affordable coverage without forgoing access to care. This year, many people can buy low-cost “catastrophic” health plans for the very first time. Combine one of these ...
How did the US become the world’s center of pharmaceutical innovation?
What kinds of policies helped the US surpass Great Britain to become the world’s center of pharmaceutical innovation? I think it was a combination of shrewd reforms on the part of the United States, and self-destructive reforms on the part of Europe and other developed nations. In the 1970s, Europe ...
Trade Policy Is The Right Way To Fight Foreign Freeloading
Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports. It’s a perfect example of how the ...
‘Soak the Rich’ Won’t Rescue Calif. Healthcare
A group of unions in California has proposed a new plan for paying for healthcare — soak the rich. That’s the idea behind the Billionaire Tax Act, a 2026 ballot initiative that would impose a 5% tax on the state’s billionaires in order to raise money for healthcare programs and ...
Competition, not price controls, just slashed GLP-1 prices
Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also dropped ...
A Healthy Dose Of Competition Sends Weight-Loss Drug Prices Plummeting
Prices for GLP-1 weight-loss medications are dropping fast. Last week, Novo Nordisk—maker of Ozempic and Wegovy—announced it would cut prices for monthly supplies of both drugs to as low as $349 for existing patients buying directly. For new customers, the price will fall to just $199 a month for the ...
Trump got shots because he knows vaccines work
The cold and flu and COVID season is here. Millions of Americans are weighing when and whether to get their shots. It’s an appropriate time to reflect on the power of vaccination and how many lives new shots have saved in recent years. As Senators Bill Cassidy and John Barrasso ...
Trump Has a Subsidy Alternative, We Should Take it Seriously
In a social media post earlier this month, President Trump laid out his own alternative to the enhanced Obamacare subsidies that fueled the record-breaking 43-day government shutdown. “I am recommending to Senate Republicans that the Hundreds of Billions of Dollars currently being sent to money sucking Insurance Companies in order ...
